Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)
China
· Delayed Price · Currency is CNY 5.87
-0.01 (-0.17%)
Apr 29, 2026, 3:00 PM CST
SHA:600613 Revenue
In the year 2025, Shanghai Shenqi Pharmaceutical Investment Management had annual revenue of 1.95B CNY, down -4.71%. Shanghai Shenqi Pharmaceutical Investment Management had revenue of 554.51M in the quarter ending December 31, 2025, with 14.21% growth.
Revenue
1.95B
Revenue Growth
-4.71%
P/S Ratio
1.53
Revenue / Employee
1.54M
Employees
1,266
Market Cap
3.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.95B | -96.44M | -4.71% |
| Dec 31, 2024 | 2.05B | -292.14M | -12.48% |
| Dec 31, 2023 | 2.34B | -47.67M | -2.00% |
| Dec 31, 2022 | 2.39B | 85.58M | 3.72% |
| Dec 31, 2021 | 2.30B | 484.03M | 26.61% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guangdong Jiaying Pharmaceutical | 410.00M |
| Zhejiang Zhenyuan Share | 2.28B |
| Hubei Guangji Pharmaceutical | 638.58M |
| Zhejiang Haisen Pharmaceutical | 520.97M |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 211.75M |
| Shandong Keyuan Pharmaceutical | 448.33M |
| Hangzhou Minsheng Healthcare | 827.65M |
| Zhejiang Int'l Group | 33.84B |